MedPath

Shanghai Yizhong Pharmaceutical Co., Ltd.

Shanghai Yizhong Pharmaceutical Co., Ltd. logo
🇨🇳China
Ownership
Public
Established
2009-09-10
Employees
304
Market Cap
-
Website
http://www.yizhongpharma.com

Clinical Trials

3

Active:0
Completed:0

Trial Phases

1 Phases

Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 3
3 (100.0%)

Polymeric Micellar Paclitaxel for Metastatic Pancreatic Cancer

First Posted Date
2024-12-31
Last Posted Date
2025-05-14
Lead Sponsor
Shanghai Yizhong Pharmaceutical Co., Ltd.
Target Recruit Count
416
Registration Number
NCT06752811
Locations
🇨🇳

Jiangsu Province Hospital, Nanjing, Jiangsu, China

🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection in the Treatment of Metastatic Breast Cancer

First Posted Date
2023-11-22
Last Posted Date
2024-11-28
Lead Sponsor
Shanghai Yizhong Pharmaceutical Co., Ltd.
Target Recruit Count
168
Registration Number
NCT06143553
Locations
🇨🇳

Jiangsu province Hospital, Nanjing, Jiangsu, China

🇨🇳

Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China

Paclitaxel Micelles for Injection / Paclitaxel Injection in Combination With Cisplatin for First-line Therapy of Advanced NSCLC

Phase 3
Conditions
Non-Small Cell Lung Cancer(NSCLC)
Interventions
First Posted Date
2016-01-29
Last Posted Date
2021-03-17
Lead Sponsor
Shanghai Yizhong Pharmaceutical Co., Ltd.
Target Recruit Count
454
Registration Number
NCT02667743
Locations
🇨🇳

Guangdong General Hospital, Guangzhou, Guangdong, China

🇨🇳

Shanghai Chest Hospital, Shanghai, Shanghai, China

🇨🇳

Jiangsu Cancer Hospital, Nanjing, Zhejiang, China

News

No news found
© Copyright 2025. All Rights Reserved by MedPath